Corbets Capital

Ownership

Private

Employees

~36

Stage

Other

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Corbets Capital General Information

Corbets Capital is an investment management firm focused on fundamental long/short US equity strategies, aiming to deliver uncorrelated returns for investors. It manages capital for Balyasny Asset Management but operates with independent portfolio teams and decision-making. The firm was founded in September 2022 and is led by experienced financial professionals.

Contact Information

Website

https://www.corbetscap.com/

Primary Industry

Investors

Corporate Office

New York City, New York
United States

Drug Pipeline

No pipeline data available

For full access to Corbets Capital's pipeline data

Book a demo

Key Partnerships

Balyasny Asset Management

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Corbets Capital Funding

No funding data available

Early Stage VC (Series A)	04-Jun-2020	$38M	Completed	Phase 1
Seed Round	12-Feb-2019	$8.5M	Completed	Startup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more

To view Corbets Capital's complete valuation and funding history, request access »